These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1773547

  • 21. Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article.
    Sandberg A, Abrahamsson B, Regårdh CG, Wieselgren I, Bergstrand R.
    J Clin Pharmacol; 1990 Feb; 30(S2):S2-16. PubMed ID: 2179280
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS, Tenero DM, Baidoo CA, Campanile AM, Harter AH, Boyle D, Danoff TM.
    Am J Cardiol; 2006 Oct 02; 98(7A):17L-26L. PubMed ID: 17023228
    [Abstract] [Full Text] [Related]

  • 23. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
    Warrington SJ, Barclay SP, John VA, Shotton PA, Good W.
    Br J Clin Pharmacol; 1985 Oct 02; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
    [Abstract] [Full Text] [Related]

  • 24. Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations.
    Gesquiere I, Darwich AS, Van der Schueren B, de Hoon J, Lannoo M, Matthys C, Rostami A, Foulon V, Augustijns P.
    Br J Clin Pharmacol; 2015 Nov 02; 80(5):1021-30. PubMed ID: 25917170
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic and pharmacodynamic comparison of conventional and controlled release formulations of metoprolol [correction of motoprolol] in healthy Chinese subjects.
    Lee YT, Liau CS, Wong EC, Chen WJ, Chen MF, Chen CC.
    Cardiovasc Drugs Ther; 1989 Aug 02; 3(4):529-33. PubMed ID: 2488104
    [Abstract] [Full Text] [Related]

  • 26. Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CR.
    Sandberg A, Ragnarsson G, Jonsson UE, Sjögren J.
    Eur J Clin Pharmacol; 1988 Aug 02; 33 Suppl():S3-7. PubMed ID: 3371391
    [Abstract] [Full Text] [Related]

  • 27. Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.
    Peters DH, Benfield P.
    Pharmacoeconomics; 1994 Oct 02; 6(4):370-400. PubMed ID: 10147474
    [Abstract] [Full Text] [Related]

  • 28. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X, Lins RL, Lens S, Demblon C, Jeanbaptiste B, Poelaert D, Stockis A.
    Int J Clin Pharmacol Ther; 1996 Feb 02; 34(2):61-70. PubMed ID: 8929748
    [Abstract] [Full Text] [Related]

  • 29. A pharmacokinetic and pharmacodynamic assessment of a combined slow-release metoprolol-chlorthalidone preparation.
    Kendall MJ, Lambert L, Quarterman CP, John VA.
    J Clin Hosp Pharm; 1981 Dec 02; 6(4):259-65. PubMed ID: 7338557
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of sustained-release tablets of metoprolol in Chinese.
    Diao Y, Li L.
    Zhongguo Yao Li Xue Bao; 1993 May 02; 14(3):232-4. PubMed ID: 8237398
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
    Kendall MJ, Jack DB, Woods KL, Laugher SJ, Quarterman CP, John VA.
    Br J Clin Pharmacol; 1982 Mar 02; 13(3):393-8. PubMed ID: 7059440
    [Abstract] [Full Text] [Related]

  • 32. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
    Freestone S, Lennard MS, Silas JH, Ramsay LE.
    Postgrad Med J; 1983 Mar 02; 59 Suppl 3():36-7. PubMed ID: 6647208
    [Abstract] [Full Text] [Related]

  • 33. Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.
    van den Berg G, van Steveninck F, Gubbens-Stibbe JM, Schoemaker HC, de Boer AG, Cohen AF.
    Eur J Clin Pharmacol; 1990 Mar 02; 39(3):315-6. PubMed ID: 2257873
    [Abstract] [Full Text] [Related]

  • 34. Receptor binding assays in analysing the bioavailability and pharmacodynamic bioequivalence of active drug moieties. A study of metoprolol.
    Kaila T, Roivas L, Neuvonen PJ.
    Eur J Clin Pharmacol; 1994 Mar 02; 46(3):237-42. PubMed ID: 8070504
    [Abstract] [Full Text] [Related]

  • 35. Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol.
    Kendall MJ.
    Drugs; 1995 Sep 02; 50(3):454-64. PubMed ID: 8521768
    [Abstract] [Full Text] [Related]

  • 36. Extended-release metoprolol succinate in chronic heart failure.
    Tangeman HJ, Patterson JH.
    Ann Pharmacother; 2003 May 02; 37(5):701-10. PubMed ID: 12708950
    [Abstract] [Full Text] [Related]

  • 37. Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.
    Dimenäs E, Dahlöf C.
    J Clin Pharmacol; 1990 Feb 02; 30(S2):S92-7. PubMed ID: 2179287
    [Abstract] [Full Text] [Related]

  • 38. Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration.
    Warrington SJ, Barclay SP, John VA, Shotton PA, Wardle HM, Good W.
    Br J Clin Pharmacol; 1985 Feb 02; 19 Suppl 2(Suppl 2):219S-224S. PubMed ID: 4005126
    [Abstract] [Full Text] [Related]

  • 39. A comparison of the beta 1-selectivity of conventional metoprolol and metoprolol CR during exercise in healthy volunteers.
    Akhlaghi S, Maxwell SR, Kendall MJ, Hughes B, Greenhaff P.
    J Clin Pharm Ther; 1993 Aug 02; 18(4):259-66. PubMed ID: 8227233
    [Abstract] [Full Text] [Related]

  • 40. Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol.
    Abrahamsson B, Edgar B, Lidman K, Wingstrand K.
    Blood Press Suppl; 1993 Aug 02; 1():10-5. PubMed ID: 8173686
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.